Acid-suppressive medication use and the risk for hospital-acquired pneumonia

JAMA

Volumn 301, Issue 20, 2009, Pages 2120-2128

  Herzig, Shoshana J ^a,b   Howell, Michael D ^a,b   Ngo, Long H ^a,b   Marcantonio, Edward R ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG INDICATION; DRUG SAFETY; DRUG USE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PNEUMONIA; PRIORITY JOURNAL; UNITED STATES; URBAN AREA; COMORBIDITY; CROSS INFECTION; DRUG UTILIZATION; HOSPITALIZATION; INTERNATIONAL CLASSIFICATION OF DISEASES; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; PROSPECTIVE STUDY; REPRODUCIBILITY; RISK; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; CROSS INFECTION; DRUG UTILIZATION; FEMALE; HISTAMINE H2 ANTAGONISTS; HOSPITALIZATION; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; PNEUMONIA; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; REPRODUCIBILITY OF RESULTS; RISK; YOUNG ADULT;

EID: 66149152644     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.722     Document Type: Article

References (42)

1. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000;95(11):3118-3122.
2. Pham CQ, Regal RE, Bostwick TR, Knauf KS. Acid suppressive therapy use on an inpatient internal medicine service. Ann Pharmacother. 2006;40(7-8):1261- 1266. (Pubitemid 44204954)
3. Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol. 2006;101(10):2200-2205. (Pubitemid 44477543)
4. Parente F, Cucino C, Gallus S, et al. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther. 2003;17(12):1503-1506. (Pubitemid 36833294)
5. Scagliarini R, Magnani E, Pratico A, Bocchini R, Sambo P, Pazzi P. Inadequate use of acid-suppressive therapy in hospitalized patients and its implications for general practice. Dig Dis Sci. 2005;50(12):2307-2311. (Pubitemid 43108975)
6. Janicki T, Stewart S. Stress-ulcer prophylaxis for general medical patients: a review of the evidence. J Hosp Med. 2007;2(2):86-92. (Pubitemid 46730491)
7. Grube RR, May DB. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am J Health Syst Pharm. 2007;64(13):1396-1400. (Pubitemid 47025538)
8. Gulmez SE, Holm A, Frederiksen H, Jensen TG, Pedersen C, Hallas J. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med. 2007;167(9):950-955. (Pubitemid 46762758)
9. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004;292(16):1955-1960. (Pubitemid 39411203)
10. Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med. 2008;149(6):391-398.
11. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. (Pubitemid 17055592)
13. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139. (Pubitemid 41587600)
14. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27. (Pubitemid 128456396)
15. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55.
16. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-Sixth Annual SAS (Users Group International Conference). http: //www2.sas.com/proceedings/sugi26/p214-26 .pdf. Accessed April 29, 2009.
17. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ. 2004;171 (1):33-38. (Pubitemid 38925116)
18. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community- acquired Clostridium difficile-associated disease. JAMA. 2005;294(23):2989-2995. (Pubitemid 41817660)
19. Lowe DO, Mamdani MM, Kopp A, Low DE, Juurlink DN. Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. Clin Infect Dis. 2006; 43(10):1272-1276. (Pubitemid 44706452)
20. Aseeri M, Schroeder T, Kramer J, Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol. 2008; 103(9):2308-2313.
21. Prod'hom G, Leuenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial. Ann Intern Med. 1994;120(8):653-662. (Pubitemid 24106177)
22. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA. 1996;275(4):308-314.
23. Messori A, Trippoli S, Vaiani M, Gorini M, Corrado A. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ. 2000;321(7269):1103-1106.
24. Kantorova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology. 2004; 51(57):757-761. (Pubitemid 38590958)
25. Apte NM, Karnad DR, Medhekar TP, Tilve GH, Morye S, Bhave GG. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial. Crit Care Med. 1992;20(5):590-593.
26. Driks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: the role of gastric colonization. N Engl J Med. 1987;317(22):1376- 1382. (Pubitemid 18052344)
27. Mallow S, Rebuck JA, Osler T, Ahern J, Healey MA, Rogers FB. Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine- 2 receptor antagonists in critically ill trauma patients? Curr Surg. 2004;61(5):452-458. (Pubitemid 39317951)
28. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis: ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm. 1999;56 (4):347-379.
29. du Moulin GC, Paterson DG, Hedley-Whyte J, Lisbon A. Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway. Lancet. 1982;1(8266):242-245.
30. Donowitz LG, Page MC, Mileur BL, Guenthner SH. Alteration of normal gastric flora in critical care patients receiving antacid and cimetidine therapy. Infect Control. 1986;7(1):23-26. (Pubitemid 16157300)
31. Garvey BM, McCambley JA, Tuxen DV. Effects of gastric alkalization on bacterial colonization in critically ill patients. Crit Care Med. 1989;17(3):211-216. (Pubitemid 19076076)
32. Hartmann M, Theiss U, Huber R, et al. Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole. Aliment Pharmacol Ther. 1996;10(3):359-366. (Pubitemid 26174911)
33. Aybay C, Imir T, Okur H. The effect of omeprazole on human natural killer cell activity. Gen Pharmacol. 1995;26(6):1413-1418.
34. Scaringi L, Cornacchione P, Fettucciari K, et al. Activity inhibition of cytolytic lymphocytes by omeprazole. Scand J Immunol. 1996;44(3):204-214. (Pubitemid 26273755)
35. Capodicasa E, De Bellis F, Pelli MA. Effect of lansoprazole on human leukocyte function. Immunopharmacol Immunotoxicol. 1999;21(2):357-377. (Pubitemid 29207219)
36. Mikawa K, Akamatsu H, Nishina K, et al. The effects of cimetidine, ranitidine, and famotidine on human neutrophil functions. Anesth Analg. 1999; 89(1):218-224. (Pubitemid 29293338)
37. Zedtwitz-Liebenstein K, Wenisch C, Patruta S, Parschalk B, Daxbock F, Graninger W. Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med. 2002;30(5):1118-1122. (Pubitemid 34508037)
38. HCUP facts and figures, 2006: statistics on hospital- based care in the United States. Healthcare Cost and Utilization Project (HCUP). http://www.hcup-us .ahrq.gov/reports/factsandfigures/facts-figures-2006 .jsp. Accessed November 8, 2008.
39. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of healthcare- associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005; 128(6):3854-3862. (Pubitemid 43062645)
40. Venditti M, Falcone M, Corrao S, Licata G, Serra P; Study Group of the Italian Society of Internal Medicine. Outcomes of patients hospitalized with community- acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med. 2009;150(1):19-26.
41. Adams K, Corrigan JM, eds; Committee on Identifying Priority Areas for Quality Improvement. Priority Areas for National Action: Transforming Health Care Quality. Rockville, MD: Agency for Healthcare Research and Quality; 2003.
42. Qadeer MA, Richter JE, Brotman DJ. Hospital-acquired gastrointestinal bleeding outside the critical care unit: risk factors, role of acid suppression, and endoscopy findings. J Hosp Med. 2006;1(1):13-20.